The recent introduction of Wegovy has garnered attention from clinical and economic stakeholders alike, causing a shift in the treatment paradigm for obesity. What can manufacturers learn from Wegovy to unlock better health for patients globally?
Learn more on our website: https://www.simon-kucher.com/en/insights/what-can-we-learn-wegovy-and-what-can-manufacturers-do-unlock-better-health-patients